Why it was recalled
Misprint on tablet
Product description
Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01
Lot numbers, UPCs & expiration codes
Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0312-2024
- Classification
- Class III
- Status
- Ongoing
- Recall initiated
- Jan 18, 2024
- FDA report date
- Feb 14, 2024
- Quantity
- 59,336 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
Original FDA data
Every field from FDA enforcement report D-0312-2024, exactly as published.
Show all FDA fields
- City
- Princeton
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 93833
- Address
- 107 College Rd E
- Code information
- Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026
- Postal code
- 08540-6623
- Report date
- Feb 14, 2024
- Product type
- Drugs
- Recall number
- D-0312-2024
- Classification
- Class III
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
- Product quantity
- 59,336 bottles
- Reason for recall
- Misprint on tablet
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01
- Distribution pattern
- Nationwide
- Recall initiation date
- Jan 18, 2024
- Initial firm notification
- Letter
- Center classification date
- Feb 6, 2024